speb/financial-data huggingface dataset:
DuPont ROE decomposition for CPPLUS.NS (quarterly period ending 2025-09-30)
ROE: 5.297639856959308%
Net margin: 7.608988773819207%
Asset turnover: 0.27596359548966093
Equity multiplier (leverage): 2.522921238882742
EBIT margin: 10.644428882731864%
Interest burden factor: 0.9554602104402902
Tax burden factor: 0.7481556719769058
ROE archetype: Standard Business
DuPont ROE decomposition for CPPLUS.NS (quarterly period ending 2025-12-31)
Net margin: 8.425876342056519%
EBIT margin: 11.204624663114187%
Interest burden factor: 0.996897354132552
Tax burden factor: 0.7543403255342392
ROE archetype: Standard Business
DuPont ROE decomposition for CPPLUS.NS (quarterly period ending 2026-03-31)
ROE: 9.011235272586033%
Net margin: 11.89342833374003%
Asset turnover: 0.3563093915176541
Equity multiplier (leverage): 2.1264246556876736
EBIT margin: 16.456837378140673%
Interest burden factor: 0.9739382363121257
Tax burden factor: 0.7420433306131046
ROE archetype: Standard Business
DuPont ROE decomposition for CPS.V (quarterly period ending 2025-03-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for CPS.V (quarterly period ending 2025-06-30)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for CPS.V (quarterly period ending 2025-09-30)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for CPS.V (quarterly period ending 2025-12-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for CPS.V (quarterly period ending 2026-03-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for CPV.AX (annual period ending 2021-06-30)
ROE: -35.46241645039672%
Equity multiplier (leverage): 1.049014964064436
ROE archetype: Low Return
DuPont ROE decomposition for CPV.AX (annual period ending 2022-06-30)
ROE: -21.126947899639518%
Net margin: -1458.6374746621327%
Asset turnover: 0.013740165995274828
Equity multiplier (leverage): 1.0541378677869706
EBIT margin: -1708.234328768171%
ROE archetype: Low Return
DuPont ROE decomposition for CPV.AX (annual period ending 2023-06-30)
ROE: -45.86312833837097%
Net margin: -11835.558363607648%
Asset turnover: 0.003586306261350988
Equity multiplier (leverage): 1.080506910875052
EBIT margin: -13608.51050386985%
ROE archetype: Low Return
DuPont ROE decomposition for CPV.AX (annual period ending 2024-06-30)
ROE: -92.94823177918656%
Net margin: -31379.096229685263%
Asset turnover: 0.002599181390779235
Equity multiplier (leverage): 1.1396306273748142
EBIT margin: -34431.00650573962%
ROE archetype: Low Return
DuPont ROE decomposition for CPX.L (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 1.5388024009124213
ROE archetype: Standard Business
DuPont ROE decomposition for CPX.L (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 1.5889421467679663
ROE archetype: Standard Business
DuPont ROE decomposition for CQE.AX (annual period ending 2022-06-30)
ROE: 24.015273311897108%
Net margin: 351.12634671890305%
Asset turnover: 0.04905823563328848
Equity multiplier (leverage): 1.3941586280814575
EBIT margin: 73.45739471106758%
Interest burden factor: 4.78
Tax burden factor: 1
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CQE.AX (annual period ending 2023-06-30)
ROE: 3.85591739371424%
Net margin: 50.822510822510814%
Asset turnover: 0.05210896225923427
Equity multiplier (leverage): 1.4559926410712396
EBIT margin: 70.82251082251082%
Interest burden factor: 0.71760391198044
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for CQE.AX (annual period ending 2024-06-30)
ROE: -1.3506381372730443%
Net margin: -16.695059625212945%
Asset turnover: 0.053028647596586945
Equity multiplier (leverage): 1.525599306882956
EBIT margin: 69.76149914821124%
Interest burden factor: -0.2393162393162393
ROE archetype: Low Return
DuPont ROE decomposition for CQE.AX (annual period ending 2025-06-30)
ROE: 4.926036601145754%
Net margin: 60.425531914893625%
Asset turnover: 0.054015016634326604
Equity multiplier (leverage): 1.5092550514423921
EBIT margin: 69.95744680851064%
Interest burden factor: 0.8637469586374696
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for CRAMC.NS (annual period ending 2025-03-31)
ROE: 31.781126912427265%
Net margin: 52.31297855875721%
Asset turnover: 0.5408449905998082
Equity multiplier (leverage): 1.1232774301710426
EBIT margin: 60.32334545163274%
Interest burden factor: 1.1716057511898277
Tax burden factor: 0.740188842774243
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CRAMC.NS (annual period ending 2026-03-31)
ROE: 28.954659672040144%
Net margin: 47.960253679887984%
Asset turnover: 0.5440573610666769
Equity multiplier (leverage): 1.1096660585643505
EBIT margin: 58.09502406193743%
Interest burden factor: 1.1124267281938527
Tax burden factor: 0.7421148474530355
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CRBP2.PA (annual period ending 2022-12-31)
ROE: 4.060794945842275%
Net margin: 28.575087041090715%
Asset turnover: 0.015375581314079083
Equity multiplier (leverage): 9.24255308271517
Tax burden factor: 0.8095528060288053
ROE archetype: Low Return
DuPont ROE decomposition for CRBP2.PA (annual period ending 2023-12-31)
ROE: 4.236576600509483%
Net margin: 31.583281632549436%
Asset turnover: 0.015180320529889785
Equity multiplier (leverage): 8.836430550341467
Tax burden factor: 0.8505809506309477
ROE archetype: Low Return
DuPont ROE decomposition for CRBP2.PA (annual period ending 2024-12-31)
ROE: 3.7283341980704634%
Net margin: 31.123361819355182%
Asset turnover: 0.014883145448508312
Equity multiplier (leverage): 8.048845792754673
Tax burden factor: 0.8541337004112474
ROE archetype: Low Return
DuPont ROE decomposition for CRBP2.PA (annual period ending 2025-12-31)
ROE: 4.496121264716228%
Net margin: 34.08754827097657%
Asset turnover: 0.01837735067257081
Equity multiplier (leverage): 7.177271048216805
Tax burden factor: 0.7747213704540653
ROE archetype: Low Return
DuPont ROE decomposition for CRD.A (quarterly period ending 2024-12-31)
ROE: 3.7678960598131805%
Net margin: 1.6356978996310538%
Asset turnover: 0.4458050027682565
Equity multiplier (leverage): 5.167147752184171
EBIT margin: 6.646330912764639%
Interest burden factor: 0.40218349779550705
Tax burden factor: 0.611923157235331
ROE archetype: Low Return
DuPont ROE decomposition for CRD.A (quarterly period ending 2025-03-31)
ROE: 4.285160248463001%
Net margin: 2.0844995500078864%
Asset turnover: 0.40518316255371195
Equity multiplier (leverage): 5.073572513939486
EBIT margin: 4.809812611531551%
Interest burden factor: 0.5928497942386831
Tax burden factor: 0.7310195227765727
ROE archetype: Low Return
DuPont ROE decomposition for CRD.A (quarterly period ending 2025-06-30)
ROE: 4.677537055424627%
Net margin: 2.3371538725922387%
Asset turnover: 0.42044477841500255
Equity multiplier (leverage): 4.760153605053175
EBIT margin: 5.237077661052915%
Interest burden factor: 0.7798322205101866
Tax burden factor: 0.5722649103549213
ROE archetype: Low Return
DuPont ROE decomposition for CRD.A (quarterly period ending 2025-12-31)
ROE: -4.223248868355966%
Net margin: -2.261892116493692%
Asset turnover: 0.4187962841816041
Equity multiplier (leverage): 4.458327500116664
EBIT margin: 6.324862693151216%
Interest burden factor: -0.3204247962459867
ROE archetype: Low Return
DuPont ROE decomposition for CRD.A (quarterly period ending 2026-03-31)
ROE: 2.8402175264318896%
Net margin: 1.5343958316412913%
Asset turnover: 0.4168445697090203
Equity multiplier (leverage): 4.440583539806123
EBIT margin: 3.738840331619425%
Interest burden factor: 0.6088227922132174
Tax burden factor: 0.674077123644847
ROE archetype: Low Return
DuPont ROE decomposition for CREG (annual period ending 2022-12-31)
ROE: -4.023105462805823%
Asset turnover: 0
Equity multiplier (leverage): 1.2558145607374995
ROE archetype: Low Return
DuPont ROE decomposition for CREG (annual period ending 2023-12-31)
ROE: -0.6714896969678457%
Asset turnover: 0
Equity multiplier (leverage): 1.2525651599372891
ROE archetype: Low Return
DuPont ROE decomposition for CREG (annual period ending 2024-12-31)
ROE: -1.4375656501618983%
Asset turnover: 0
Equity multiplier (leverage): 1.2049602702280506
ROE archetype: Low Return
DuPont ROE decomposition for CREG (annual period ending 2025-12-31)
ROE: -2.381214242659005%
Net margin: -1104.7396470216258%
Asset turnover: 0.0019168572468673563
Equity multiplier (leverage): 1.124472296211455
EBIT margin: -1148.762518618409%
ROE archetype: Low Return
DuPont ROE decomposition for CRISIL.NS (annual period ending 2022-12-31)
ROE: 31.495329188941838%
Net margin: 20.384509809587104%
Asset turnover: 0.9780007064641469
Equity multiplier (leverage): 1.5798167390261053
EBIT margin: 22.66643069721749%
Interest burden factor: 1.1829756043150566
Tax burden factor: 0.760223599137931
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CRISIL.NS (annual period ending 2023-12-31)
ROE: 33.17446750912121%
Net margin: 20.972632759147896%
Asset turnover: 1.0276769072532346
Equity multiplier (leverage): 1.5391977177409424
EBIT margin: 24.824495464274793%
Interest burden factor: 1.1133351296560041
Tax burden factor: 0.7588336982828167
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CRISIL.NS (annual period ending 2024-12-31)
ROE: 28.227012949023177%
Net margin: 20.985158507629347%
Asset turnover: 0.8830276973765413
Equity multiplier (leverage): 1.5232750982947783
EBIT margin: 25.81033075851745%
Interest burden factor: 1.101157649519825
Tax burden factor: 0.7383617386423736
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CRISIL.NS (annual period ending 2025-12-31)
ROE: 26.79645854753261%
Net margin: 20.992269136012233%
Asset turnover: 0.8330147961407589
Equity multiplier (leverage): 1.5323758528254254
EBIT margin: 26.2312243594838%
Interest burden factor: 1.087601078167116
Tax burden factor: 0.7358193327761927
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CRK (quarterly period ending 2025-03-31)
ROE: -5.0673551193052475%
Net margin: -22.500165739177234%
Asset turnover: 0.07768694216673759
Equity multiplier (leverage): 2.8989958650684353
EBIT margin: 24.601153544673533%
Interest burden factor: -2.0501949781244058
ROE archetype: Low Return
DuPont ROE decomposition for CRK (quarterly period ending 2025-06-30)
ROE: 5.548666599746055%
Net margin: 27.798971637087412%
Asset turnover: 0.07073518340664886
Equity multiplier (leverage): 2.8217882191852337
EBIT margin: 19.02046093454287%
Interest burden factor: 3.0433445877959886
Tax burden factor: 0.4802380471318627
ROE archetype: Standard Business
DuPont ROE decomposition for CRK (quarterly period ending 2025-09-30)
ROE: 4.674710059637693%
Net margin: 26.25285649502503%
Asset turnover: 0.0664682011983579
Equity multiplier (leverage): 2.678947417378946
EBIT margin: 11.716297804611294%
Interest burden factor: 2.5940500132812203
Tax burden factor: 0.8637892950659002
ROE archetype: Low Return
DuPont ROE decomposition for CRK (quarterly period ending 2025-12-31)
ROE: 10.948816038380759%
Net margin: 61.67167625857165%
Asset turnover: 0.07154549862778563
Equity multiplier (leverage): 2.4814132172717
EBIT margin: 23.146736969173347%
Interest burden factor: 3.126219857846771
Tax burden factor: 0.8522685427987994
ROE archetype: Standard Business
DuPont ROE decomposition for CRK (quarterly period ending 2026-03-31)
ROE: 3.7292574783464953%
Net margin: 19.213060215119874%
Asset turnover: 0.08219891149972507
Equity multiplier (leverage): 2.361346714801588
EBIT margin: 29.55780535374547%
Interest burden factor: 0.7192943936303597
Tax burden factor: 0.9036862694695917
ROE archetype: Low Return
DuPont ROE decomposition for CRL (annual period ending 2022-12-31)
ROE: 16.29261403569698%
Net margin: 12.389350261313965%
Asset turnover: 0.5229751787835223
Equity multiplier (leverage): 2.514555127244704
EBIT margin: 16.372363596122792%
Interest burden factor: 0.9570060294174123
Tax burden factor: 0.7907195495251105
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CRL (annual period ending 2023-12-31)
ROE: 14.37694827821252%
Net margin: 11.632899526300253%
Asset turnover: 0.5227837522141573
Equity multiplier (leverage): 2.364049967504691
EBIT margin: 14.947925962286613%
Interest burden factor: 0.9417150929671565
Tax burden factor: 0.8263946711074105
ROE archetype: Standard Business
DuPont ROE decomposition for CRL (annual period ending 2024-12-31)
ROE: 0.705755038735462%
Net margin: 0.6244708318960867%
Asset turnover: 0.515156125165725
Equity multiplier (leverage): 2.19382995241016
EBIT margin: 10.922177813322456%
Interest burden factor: 0.21049990166091326
Tax burden factor: 0.27161329123440087
ROE archetype: Low Return
DuPont ROE decomposition for CRL (annual period ending 2025-12-31)
ROE: -4.231500079175244%
Net margin: -3.540460160452978%
Asset turnover: 0.5476603658527853
Equity multiplier (leverage): 2.1823446051893716
EBIT margin: 9.989983518380068%
Interest burden factor: -0.2480530293965139
ROE archetype: Low Return
DuPont ROE decomposition for CRTA.L (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 1.558759009714823
ROE archetype: Standard Business
DuPont ROE decomposition for CRTA.L (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 1.3028526768268853
ROE archetype: Standard Business
DuPont ROE decomposition for CRTX.L (annual period ending 2021-12-31)
ROE: -4.0051808309255765%
Asset turnover: 0
Equity multiplier (leverage): 1.037428182391817
ROE archetype: Low Return
DuPont ROE decomposition for CRTX.L (annual period ending 2022-12-31)
ROE: -10.37107937267462%
Asset turnover: 0
Equity multiplier (leverage): 1.0353585783579717
ROE archetype: Low Return
DuPont ROE decomposition for CRTX.L (annual period ending 2023-12-31)
ROE: -1.8421839137223717%
Net margin: -435.5555555555556%
Asset turnover: 0.0039592728500631065
Equity multiplier (leverage): 1.0682526927839409
EBIT margin: -377.77777777777777%
ROE archetype: Low Return
DuPont ROE decomposition for CRTX.L (annual period ending 2024-12-31)
ROE: -140.12126524947035%
Net margin: -2428%
Asset turnover: 0.025712128313284385
Equity multiplier (leverage): 2.2444882752575057
EBIT margin: -3520.0000000000005%
ROE archetype: Low Return
DuPont ROE decomposition for CRTX.L (annual period ending 2025-12-31)
ROE: -136.8880097109203%
Net margin: -823.8095238095237%
Asset turnover: 0.1328808099401749
Equity multiplier (leverage): 1.250478802319831
EBIT margin: -812.9870129870129%
ROE archetype: Low Return
DuPont ROE decomposition for CRVL (annual period ending 2023-03-31)
ROE: 32.82536008230453%
Net margin: 9.235807070231935%
Asset turnover: 1.8241179113684654
Equity multiplier (leverage): 1.9484162314023425
EBIT margin: 11.767112649987057%
Interest burden factor: 1
Tax burden factor: 0.7848830333278142
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CRVL (annual period ending 2024-03-31)
ROE: 33.90311300222532%
Net margin: 9.587695882491252%
Asset turnover: 1.8744028413791154
Equity multiplier (leverage): 1.8865242550958932
EBIT margin: 11.95771214028223%
Interest burden factor: 1
Tax burden factor: 0.801800191375485
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CRVL (annual period ending 2025-03-31)
ROE: 33.412682529483845%
Net margin: 10.625967938418182%
Asset turnover: 1.7900055463671296
Equity multiplier (leverage): 1.7566630503094969
EBIT margin: 13.491009827052364%
Interest burden factor: 1
Tax burden factor: 0.7876332516718533
ROE archetype: Asset-Light Turnover Play
DuPont ROE decomposition for CRVL (annual period ending 2026-03-31)
ROE: 30.812964767710387%
Net margin: 11.511830131023956%
Asset turnover: 1.6123761735026014
Equity multiplier (leverage): 1.6600560164642608
EBIT margin: 14.932391054190441%
Interest burden factor: 1
Tax burden factor: 0.7709301269466433
ROE archetype: Asset-Light Turnover Play
DuPont ROE decomposition for CRW.L (annual period ending 2021-06-30)
ROE: 4.958141071696142%
Net margin: 17.07507475720448%
Asset turnover: 0.24254813863928112
Equity multiplier (leverage): 1.1971768755835086
EBIT margin: 26.163698430760274%
Interest burden factor: 0.6657732375847073
Tax burden factor: 0.9802506646410938
ROE archetype: Low Return
DuPont ROE decomposition for CRW.L (annual period ending 2022-06-30)
ROE: 2.989590000207853%
Net margin: 5.683685304209153%
Asset turnover: 0.35954772013940806
Equity multiplier (leverage): 1.4629351307142455
EBIT margin: 11.231455081428503%
Interest burden factor: 0.7046738019684827
Tax burden factor: 0.7181346359334453
ROE archetype: Low Return
DuPont ROE decomposition for CRW.L (annual period ending 2023-06-30)
ROE: 2.846398968260085%
Net margin: 5.305198312818214%
Asset turnover: 0.3101267693523167
Equity multiplier (leverage): 1.730035024261304
EBIT margin: 9.864496776195567%
Interest burden factor: 0.7622626121402772
Tax burden factor: 0.7055406954528085
ROE archetype: Low Return
DuPont ROE decomposition for CRW.L (annual period ending 2024-06-30)
ROE: 3.5656342688438882%
Net margin: 6.183295644271615%
Asset turnover: 0.33778826393344463
Equity multiplier (leverage): 1.7071521389083124
EBIT margin: 11.013483526005453%
Interest burden factor: 0.7554329575437755
Tax burden factor: 0.7431891788912174
ROE archetype: Low Return
DuPont ROE decomposition for CRWS (annual period ending 2022-03-31)
ROE: 21.654549027313813%
Net margin: 11.353021978021978%
Asset turnover: 1.4522483584074475
Equity multiplier (leverage): 1.3133992707582804
EBIT margin: 11.797161172161172%
Interest burden factor: 1.1960023287405395
Tax burden factor: 0.8046405971117963
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CRWS (annual period ending 2023-03-31)
ROE: 11.892859022259643%
Net margin: 7.528013537100449%
Asset turnover: 0.9932440927167216
Equity multiplier (leverage): 1.5905593853602062
EBIT margin: 9.557246212676375%
Interest burden factor: 1.0352711557228496
Tax burden factor: 0.7608402908699166
ROE archetype: Standard Business
DuPont ROE decomposition for CRWS (annual period ending 2024-03-31)
ROE: 9.708872687596092%
Net margin: 5.584717911265291%
Asset turnover: 1.009131841684036
Equity multiplier (leverage): 1.7227396716758419
EBIT margin: 7.868130363337593%
Interest burden factor: 0.9032632342277013
Tax burden factor: 0.785806037251124
ROE archetype: Standard Business
DuPont ROE decomposition for CRWS (annual period ending 2025-03-31)
ROE: -20.51304538478404%
Net margin: -10.723209169054442%
Asset turnover: 1.064933479799829
Equity multiplier (leverage): 1.796316597237448
EBIT margin: 2.9512893982808026%
Interest burden factor: -4.8205825242718445
ROE archetype: Low Return
DuPont ROE decomposition for CRWS (annual period ending 2026-03-31)
ROE: 4.699612403100775%
Net margin: 2.240293681472297%
Asset turnover: 1.0838235390989874
Equity multiplier (leverage): 1.9355237658098736
EBIT margin: 1.3359103396299807%
Interest burden factor: 2.400363967242948
Tax burden factor: 0.6986353297952995
ROE archetype: Low Return
DuPont ROE decomposition for CRWV (annual period ending 2022-12-31)
Net margin: -196.17814276689828%
EBIT margin: -144.53569172457358%
ROE archetype: Standard Business
DuPont ROE decomposition for CRWV (annual period ending 2023-12-31)
Net margin: -259.3886462882096%
Asset turnover: 0.04601188472917787
EBIT margin: -6.11353711790393%
ROE archetype: Standard Business
DuPont ROE decomposition for CRWV (annual period ending 2024-12-31)
Net margin: -45.06527415143603%
Asset turnover: 0.16790899595462072
EBIT margin: 16.91906005221932%
Interest burden factor: -2.2962962962962963
ROE archetype: Standard Business
DuPont ROE decomposition for CRWV (annual period ending 2025-12-31)
ROE: -79.90414241698048%
Net margin: -22.74410446306763%
Asset turnover: 0.15285618529827957
Equity multiplier (leverage): 22.983567271482368
EBIT margin: -0.896511401286299%
ROE archetype: Low Return
DuPont ROE decomposition for CS1.DE (annual period ending 2022-12-31)
ROE: 54.09907935116177%
Net margin: 43.135541379009%
Asset turnover: 0.7397853633307474
Equity multiplier (leverage): 1.6953090749671196
EBIT margin: 32.57013021060911%
Interest burden factor: 0.9796082640193184
Tax burden factor: 1.3519583675705287
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CS1.DE (annual period ending 2023-12-31)
ROE: 24.369112980405987%
Net margin: 31.112540192926048%
Asset turnover: 0.5210427556627798
Equity multiplier (leverage): 1.50324887926258
EBIT margin: 30.456591639871384%
Interest burden factor: 1.3163006756756757
Tax burden factor: 0.7760667308309271
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CS1.DE (annual period ending 2024-12-31)
ROE: -5.047006432459178%
Net margin: -16.91542288557214%
Asset turnover: 0.19971611071682044
Equity multiplier (leverage): 1.493956315826677
EBIT margin: -16.512674721629946%
ROE archetype: Low Return
DuPont ROE decomposition for CS1.DE (annual period ending 2025-12-31)
ROE: 10.065572863348367%
Net margin: 14.923291492329149%
Asset turnover: 0.4339189405670956
Equity multiplier (leverage): 1.5544088758542456
EBIT margin: 22.733612273361228%
Interest burden factor: 0.8235294117647058
Tax burden factor: 0.7971078001752848
ROE archetype: Standard Business
DuPont ROE decomposition for CSG.V (quarterly period ending 2024-12-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for CSG.V (quarterly period ending 2025-03-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for CSG.V (quarterly period ending 2025-06-30)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for CSG.V (quarterly period ending 2025-09-30)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for CSG.V (quarterly period ending 2025-12-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for CSG.V (quarterly period ending 2026-03-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for CSLFINANCE.NS (annual period ending 2022-03-31)
ROE: 10.404336244318724%
Net margin: 46.343700468848716%
Asset turnover: 0.13561171618429804
Equity multiplier (leverage): 1.6554896066748201
EBIT margin: 63.80498996907594%
Interest burden factor: 0.9718125439716497
Tax burden factor: 0.7474008084139401
ROE archetype: Standard Business
DuPont ROE decomposition for CSLFINANCE.NS (annual period ending 2023-03-31)
ROE: 12.842268763379344%
Net margin: 39.840353590079644%
Asset turnover: 0.1690476961375072
Equity multiplier (leverage): 1.906818312143362
EBIT margin: 54.65645548996273%
Interest burden factor: 0.9829752224547502
Tax burden factor: 0.7415477976249486
ROE archetype: Standard Business
DuPont ROE decomposition for CSLFINANCE.NS (annual period ending 2024-03-31)
ROE: 15.03176162590886%
Net margin: 38.93929579732572%
Asset turnover: 0.18321160223918137
Equity multiplier (leverage): 2.107020757539445
EBIT margin: 53.535455339902484%
Interest burden factor: 0.9825858367867025
Tax burden factor: 0.7402460395345577
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CSLFINANCE.NS (annual period ending 2025-03-31)
ROE: 14.016053370791603%
Net margin: 34.18316254246064%
Asset turnover: 0.18698486439386136
Equity multiplier (leverage): 2.1928405254755248
EBIT margin: 49.167382641729866%
Interest burden factor: 0.9342935890586395
Tax burden factor: 0.7441350850319775
ROE archetype: Standard Business
DuPont ROE decomposition for CSLFINANCE.NS (annual period ending 2026-03-31)
ROE: 14.127249728397063%
Net margin: 34.21671676047003%
Asset turnover: 0.17592201650205652
Equity multiplier (leverage): 2.3469243613225528
EBIT margin: 46.980782099107856%
Interest burden factor: 0.9481715671846295
Tax burden factor: 0.7681236987599082
ROE archetype: Standard Business
DuPont ROE decomposition for CSNA3.SA (annual period ending 2022-12-31)
ROE: 9.936256087492309%
Net margin: 4.247538719808637%
Asset turnover: 0.5979098735894671
Equity multiplier (leverage): 3.9124581431903978
EBIT margin: 17.35122441583993%
Interest burden factor: 0.465997580366753
Tax burden factor: 0.5253195432282136
ROE archetype: Standard Business
DuPont ROE decomposition for CSNA3.SA (annual period ending 2023-12-31)
ROE: 2.027222874107706%
Net margin: 0.774616717676582%
Asset turnover: 0.6117758909139839
Equity multiplier (leverage): 4.277817710212322
EBIT margin: 12.600941619995085%
Interest burden factor: 0.15807076678521081
Tax burden factor: 0.3888949522246701
ROE archetype: Low Return
DuPont ROE decomposition for CSNA3.SA (annual period ending 2024-12-31)
ROE: -7.587877084228095%
Net margin: -3.0409204738150137%
Asset turnover: 0.45871299525216425
Equity multiplier (leverage): 5.439690377665259
EBIT margin: 7.892054767611543%
Interest burden factor: -0.38661879990400594
ROE archetype: Low Return
DuPont ROE decomposition for CSNA3.SA (annual period ending 2025-12-31)
ROE: -10.23436910679964%
Net margin: -2.9361978166929057%
Asset turnover: 0.5325602143761164
Equity multiplier (leverage): 6.544960739934408
EBIT margin: 10.190402721607883%
Interest burden factor: -0.32117693111894774
ROE archetype: Low Return
DuPont ROE decomposition for CSQ (annual period ending 2022-10-31)
ROE: -27.958590658043537%
Asset turnover: -0.1827188988079315
Equity multiplier (leverage): 1.5257551831712903
ROE archetype: Low Return
DuPont ROE decomposition for CSQ (annual period ending 2023-10-31)
ROE: 7.878021167545662%
Net margin: 99.0711820666283%
Asset turnover: 0.05200960365948466
Equity multiplier (leverage): 1.5289252546229515
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for CSQ (annual period ending 2024-10-31)
ROE: 34.7181604062995%
Net margin: 99.7866721621973%
Asset turnover: 0.23152314559563308
Equity multiplier (leverage): 1.5027604325930044
Tax burden factor: 1
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CSQ (annual period ending 2025-10-31)
ROE: 23.45314486623473%
Net margin: 99.72958323712751%
Asset turnover: 0.16216011648728423
Equity multiplier (leverage): 1.4502171420119583
Tax burden factor: 1
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CSX (annual period ending 2022-12-31)
ROE: 32.58613861386139%
Net margin: 27.69810812630445%
Asset turnover: 0.354385378889101
Equity multiplier (leverage): 3.3197623762376236
EBIT margin: 39.015687066585876%
Interest burden factor: 0.9223468507333908
Tax burden factor: 0.7696913002806361
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CSX (annual period ending 2023-12-31)
ROE: 29.80902072328322%
Net margin: 25.025585044688547%
Asset turnover: 0.3484617944938424
Equity multiplier (leverage): 3.4182852498984153
EBIT margin: 37.71576721020673%
Interest burden factor: 0.8735528219971056
Tax burden factor: 0.7595775522882584
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CSX (annual period ending 2024-12-31)
ROE: 28.335783112853175%
Net margin: 23.86519944979367%
Asset turnover: 0.34221427226511014
Equity multiplier (leverage): 3.469541074636616
EBIT margin: 37.1595598349381%
Interest burden factor: 0.8430501573200074
Tax burden factor: 0.7618002195389681
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CSX (annual period ending 2025-12-31)
ROE: 22.511395955896678%
Net margin: 20.500993471473176%
Asset turnover: 0.32603012285125976
Equity multiplier (leverage): 3.367982233996961
EBIT margin: 33.479988646040304%
Interest burden factor: 0.7988554472233997
Tax burden factor: 0.7665163173255506
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CTAA (quarterly period ending 2025-10-31)
Equity multiplier (leverage): 16.02079580808908
ROE archetype: Standard Business
DuPont ROE decomposition for CTAA (quarterly period ending 2026-03-31)
ROE: 0.32586004256415907%
Asset turnover: 0
Equity multiplier (leverage): 1.0002017486210768
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for CTEC.L (annual period ending 2022-12-31)
ROE: 3.907560414984159%
Net margin: 3.0349819059107364%
Asset turnover: 0.5769766146993318
Equity multiplier (leverage): 2.2314717028017643
EBIT margin: 10.668275030156815%
Interest burden factor: 0.3704206241519674
Tax burden factor: 0.7680097680097681
ROE archetype: Low Return
DuPont ROE decomposition for CTEC.L (annual period ending 2023-12-31)
ROE: 8.081060926457557%
Net margin: 6.081964152352502%
Asset turnover: 0.600735365286549
Equity multiplier (leverage): 2.21177693823965
EBIT margin: 12.378640776699028%
Interest burden factor: 0.6312217194570137
Tax burden factor: 0.7783751493428913
ROE archetype: Standard Business
DuPont ROE decomposition for CTEC.L (annual period ending 2024-12-31)
ROE: 11.224971824123015%
Net margin: 8.344255133245959%
Asset turnover: 0.6292170409251523
Equity multiplier (leverage): 2.137948349804908
EBIT margin: 14.5041502839668%
Interest burden factor: 0.7409638554216867
Tax burden factor: 0.7764227642276422
ROE archetype: Standard Business
DuPont ROE decomposition for CTEC.L (annual period ending 2025-12-31)
ROE: 11.362437405143938%
Net margin: 7.175071750717507%
Asset turnover: 0.6936490161574149
Equity multiplier (leverage): 2.2829977356285456
EBIT margin: 15.826158261582615%
Interest burden factor: 0.5958549222797928
Tax burden factor: 0.7608695652173914
ROE archetype: Standard Business
DuPont ROE decomposition for CTEV (annual period ending 2022-12-31)
ROE: -31.99656863675915%
Net margin: -53.06136058000437%
Asset turnover: 0.14647955041741373
Equity multiplier (leverage): 4.11668868979337
EBIT margin: 30.950916722545557%
Interest burden factor: -1.6779569216774093
ROE archetype: Low Return
DuPont ROE decomposition for CTEV (annual period ending 2023-12-31)
ROE: -5.240328648505314%
Net margin: -9.53663143093672%
Asset turnover: 0.13414313866601432
Equity multiplier (leverage): 4.096331192748108
EBIT margin: 17.77605135181233%
Interest burden factor: -0.6263712475354111
ROE archetype: Low Return
DuPont ROE decomposition for CTEV (annual period ending 2024-12-31)
ROE: -183.56910145632312%
Net margin: -176.85241300460766%
Asset turnover: 0.15362517842825324
Equity multiplier (leverage): 6.756568622967678
EBIT margin: 11.632624991403617%
Interest burden factor: -16.356710020691693
ROE archetype: Low Return
DuPont ROE decomposition for CTEV (annual period ending 2025-12-31)
Net margin: -29.44667204605697%
Asset turnover: 0.1923270432107466
EBIT margin: 4.66722532221961%
Interest burden factor: -8.27995028629766
ROE archetype: Standard Business
DuPont ROE decomposition for CTNT (annual period ending 2022-12-31)
ROE: 44.27224030064676%
Net margin: 1.4812884841868583%
Asset turnover: 3.7469815353936884
Equity multiplier (leverage): 7.976461981569942
EBIT margin: 6.3964273420637205%
Interest burden factor: 0.29804585975056147
Tax burden factor: 0.7769965352904868
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CTNT (annual period ending 2023-12-31)
ROE: 3.059891659218081%
Asset turnover: 0
Equity multiplier (leverage): 2.831853387600867
ROE archetype: Low Return
DuPont ROE decomposition for CTNT (annual period ending 2024-12-31)
ROE: -53.15820369526132%
Net margin: -1138.3929531268855%
Asset turnover: 0.03583553086930203
Equity multiplier (leverage): 1.3030595267975598
EBIT margin: -818.7463937429383%
ROE archetype: Low Return
DuPont ROE decomposition for CTNT (annual period ending 2025-12-31)
ROE: -33.21949647978937%
Net margin: -283.2441623672136%
Asset turnover: 0.094613398865508
Equity multiplier (leverage): 1.2395939082136154
EBIT margin: -298.3807204455289%
ROE archetype: Low Return
DuPont ROE decomposition for CTOS (quarterly period ending 2025-03-31)
ROE: -2.187187660971775%
Net margin: -4.213560317550541%
Asset turnover: 0.11917667633480745
Equity multiplier (leverage): 4.355575662727327
EBIT margin: 3.8047803103507074%
Interest burden factor: -1.586803610333022
ROE archetype: Low Return
DuPont ROE decomposition for CTOS (quarterly period ending 2025-06-30)
ROE: -3.5396552390763967%
Net margin: -5.548571506775396%
Asset turnover: 0.14367839016426232
Equity multiplier (leverage): 4.440054728707502
EBIT margin: 6.497576654551569%
Interest burden factor: -0.32803755190467593
ROE archetype: Low Return
DuPont ROE decomposition for CTOS (quarterly period ending 2025-09-30)
ROE: -0.7310092843005088%
Net margin: -1.1940471893423612%
Asset turnover: 0.13545461966207575
Equity multiplier (leverage): 4.519678894392907
EBIT margin: 7.442050541636068%
Interest burden factor: -0.18798606271777005
ROE archetype: Low Return
DuPont ROE decomposition for CTOS (quarterly period ending 2025-12-31)
ROE: 2.6195503157577718%
Net margin: 3.952221195643942%
Asset turnover: 0.15129527949871108
Equity multiplier (leverage): 4.380867557418347
EBIT margin: 10.679611650485436%
Interest burden factor: 0.26606155155297123
Tax burden factor: 1.3909248400852878
ROE archetype: Low Return
DuPont ROE decomposition for CTOS (quarterly period ending 2026-03-31)
ROE: -0.5081940404275669%
Net margin: -0.8886058290116156%
Asset turnover: 0.13210412147505424
Equity multiplier (leverage): 4.32916404434247
EBIT margin: 7.660163510404616%
Interest burden factor: -0.1076044229518396
ROE archetype: Low Return
DuPont ROE decomposition for CTP2.DE (quarterly period ending 2025-03-31)
ROE: 3.865979381443299%
Net margin: 11.292535215980191%
Asset turnover: 0.1116144452328491
Equity multiplier (leverage): 3.0672394043528066
EBIT margin: 18.934653862883525%
Interest burden factor: 0.7937798197561406
Tax burden factor: 0.7513357079252003
ROE archetype: Low Return
DuPont ROE decomposition for CTP2.DE (quarterly period ending 2025-06-30)
ROE: 12.040615291354095%
Net margin: 36.69382773067661%
Asset turnover: 0.1119345666703593
Equity multiplier (leverage): 2.931510408209658
EBIT margin: 19.770395539867383%
Interest burden factor: 2.4440180210245286
Tax burden factor: 0.7594046562435993
ROE archetype: Standard Business
DuPont ROE decomposition for CTP2.DE (quarterly period ending 2025-09-30)
ROE: 3.4157893118189184%
Net margin: 10.680171805884992%
Asset turnover: 0.11410180215600399
Equity multiplier (leverage): 2.8029821521933016
EBIT margin: 17.73511122507853%
Interest burden factor: 0.8075185252123622
Tax burden factor: 0.7457475380483438
ROE archetype: Low Return
DuPont ROE decomposition for CTP2.DE (quarterly period ending 2025-12-31)
ROE: 2.223452915718007%
Net margin: 6.709996904982978%
Asset turnover: 0.11843277263180274
Equity multiplier (leverage): 2.797909872212992
EBIT margin: 10.789229340761375%
Interest burden factor: 0.6193344807802639
Tax burden factor: 1.0041685965724874
ROE archetype: Low Return
DuPont ROE decomposition for CTP2.DE (quarterly period ending 2026-03-31)
ROE: 2.338690591449902%
Net margin: 6.911021394284261%
Asset turnover: 0.11811885482123714
Equity multiplier (leverage): 2.8649121108457583
EBIT margin: 13.144927996948216%
Interest burden factor: 0.6609431680773882
Tax burden factor: 0.7954628613245518
ROE archetype: Low Return
DuPont ROE decomposition for CTP2.DE (quarterly period ending 2026-06-30)
ROE: 3.950810947085352%
Net margin: 11.77688710754843%
Asset turnover: 0.11569896628345087
Equity multiplier (leverage): 2.899520994985854
EBIT margin: 17.234468937875754%
Interest burden factor: 0.8937984496124031
Tax burden factor: 0.7645273200346921
ROE archetype: Low Return
DuPont ROE decomposition for CU6.AX (annual period ending 2022-06-30)
ROE: -25.753984858104058%
Equity multiplier (leverage): 1.0822386604422929
ROE archetype: Low Return
DuPont ROE decomposition for CU6.AX (annual period ending 2023-06-30)
ROE: -29.77983622846121%
Equity multiplier (leverage): 1.0945356787246054
ROE archetype: Low Return
DuPont ROE decomposition for CU6.AX (annual period ending 2024-06-30)
ROE: -39.368813905001105%
Equity multiplier (leverage): 1.074419752777885
ROE archetype: Low Return
DuPont ROE decomposition for CU6.AX (annual period ending 2025-06-30)
ROE: -53.70172049518123%
Equity multiplier (leverage): 1.0811841162201774
ROE archetype: Low Return
DuPont ROE decomposition for CUB (annual period ending 2024-12-31)
Equity multiplier (leverage): 1.0439970168923172
ROE archetype: Standard Business
DuPont ROE decomposition for CUB (annual period ending 2025-12-31)
ROE: 3.860769967454965%
Asset turnover: 0
Equity multiplier (leverage): 1.0433721615599727
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for CUB.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 8.036800774855333
ROE archetype: Standard Business
DuPont ROE decomposition for CUB.NS (quarterly period ending 2024-12-31)
Net margin: 35.04281725256708%
Tax burden factor: 0.7922411199699496
ROE archetype: Standard Business
DuPont ROE decomposition for CUB.NS (quarterly period ending 2025-03-31)
ROE: 3.041882796317149%
Net margin: 33.81686637986006%
Asset turnover: 0.010970143417752208
Equity multiplier (leverage): 8.199678222966494
Tax burden factor: 0.7933675957410583
ROE archetype: Low Return
DuPont ROE decomposition for CUB.NS (quarterly period ending 2025-06-30)
Net margin: 35.19701414060761%
Tax burden factor: 0.8031080574483435
ROE archetype: Standard Business
DuPont ROE decomposition for CUB.NS (quarterly period ending 2025-12-31)
Net margin: 33.29861061683063%
Tax burden factor: 0.7962416899570406
ROE archetype: Standard Business
DuPont ROE decomposition for CUB.NS (quarterly period ending 2026-03-31)
ROE: 3.4034032735984723%
Net margin: 33.40720614351226%
Asset turnover: 0.011093183294586514
Equity multiplier (leverage): 9.183686846035082
Tax burden factor: 0.7824028771561972
ROE archetype: Low Return
DuPont ROE decomposition for CUCU.V (annual period ending 2022-11-30)
ROE: -43.99949624525515%
Asset turnover: 0
Equity multiplier (leverage): 1.0272141476608945
ROE archetype: Low Return
DuPont ROE decomposition for CUCU.V (annual period ending 2023-11-30)
ROE: -170.56933289941716%
Asset turnover: 0
Equity multiplier (leverage): 1.0893108698274272
ROE archetype: Low Return
DuPont ROE decomposition for CUCU.V (annual period ending 2024-11-30)
ROE: -193.13731850645183%
Asset turnover: 0
Equity multiplier (leverage): 1.9985601076268331
ROE archetype: Low Return
DuPont ROE decomposition for CUCU.V (annual period ending 2025-11-30)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for CUPID.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 1.118554445756633
ROE archetype: Standard Business
DuPont ROE decomposition for CUPID.NS (quarterly period ending 2025-03-31)
ROE: 3.3638395720768703%
Net margin: 20.379662121249677%
Asset turnover: 0.15192435871296628
Equity multiplier (leverage): 1.0864528512184524
EBIT margin: 21.502147594446352%
Interest burden factor: 1.317213951650089
Tax burden factor: 0.7195464234589587
ROE archetype: Low Return
DuPont ROE decomposition for CUPID.NS (quarterly period ending 2025-06-30)
Net margin: 25.093930430449678%
EBIT margin: 25.4686488899739%
Interest burden factor: 1.2836161901322916
Tax burden factor: 0.7675869758687357
ROE archetype: Standard Business
DuPont ROE decomposition for CUPID.NS (quarterly period ending 2025-09-30)
ROE: 6.330235348715435%
Net margin: 28.573966094629995%
Asset turnover: 0.19097379975372605
Equity multiplier (leverage): 1.1600468855797197
EBIT margin: 32.10080192499893%
Interest burden factor: 1.187438440908806
Tax burden factor: 0.7496240975233929
ROE archetype: Standard Business
DuPont ROE decomposition for CUPID.NS (quarterly period ending 2025-12-31)
Net margin: 35.118198328473916%
EBIT margin: 35.29457064197811%
Interest burden factor: 1.3113719286761945
Tax burden factor: 0.7587495407141057
ROE archetype: Standard Business
DuPont ROE decomposition for CUPID.NS (quarterly period ending 2026-03-31)
ROE: 8.043929337200186%
Net margin: 30.228397896995457%
Asset turnover: 0.21684102033135932
Equity multiplier (leverage): 1.2271896235585258
EBIT margin: 30.211392469429832%
Interest burden factor: 1.309292231962276
Tax burden factor: 0.7642013424233164
ROE archetype: Standard Business
DuPont ROE decomposition for CURA.TO (quarterly period ending 2025-03-31)
ROE: -6.255425189492264%
Net margin: -19.64816844082655%
Asset turnover: 0.10403107523952247
Equity multiplier (leverage): 3.0603540649984424
EBIT margin: 3.0545554164057607%
Interest burden factor: -1.7510143070681188
ROE archetype: Low Return
DuPont ROE decomposition for CURA.TO (quarterly period ending 2025-06-30)
ROE: -6.8503375810370954%
Net margin: -20.67340709652804%
Asset turnover: 0.10726720659509835
Equity multiplier (leverage): 3.0891069602746373
EBIT margin: 1.0444486837085083%
Interest burden factor: -5.851141552511415
ROE archetype: Low Return
DuPont ROE decomposition for CURA.TO (quarterly period ending 2025-09-30)
ROE: -6.223919002530347%
Net margin: -17.700253556663046%
Asset turnover: 0.11042685217576008
Equity multiplier (leverage): 3.1842690238590516
EBIT margin: 1.2587277201134135%
Interest burden factor: -6.030265442818159
ROE archetype: Low Return
DuPont ROE decomposition for CURA.TO (quarterly period ending 2025-12-31)
ROE: -11.5737461273053%
Net margin: -30.897378805309188%
Asset turnover: 0.11289422459409501
Equity multiplier (leverage): 3.318032146913631
EBIT margin: 3.187738894867703%
Interest burden factor: -1.6244664338377959
ROE archetype: Low Return
DuPont ROE decomposition for CURA.TO (quarterly period ending 2026-03-31)
ROE: 7.979810105236683%
Net margin: 21.527552886676474%
Asset turnover: 0.11463218413358711
Equity multiplier (leverage): 3.2336374393359972
EBIT margin: 0.23224182758588785%
Interest burden factor: -38.0199203187251
ROE archetype: Standard Business
DuPont ROE decomposition for CVC.AX (annual period ending 2022-06-30)
ROE: 7.328610905633166%
Net margin: 19.010849585633526%
Asset turnover: 0.2431524692453353
Equity multiplier (leverage): 1.5854094939672192
EBIT margin: 23.609485496919348%
Interest burden factor: 0.9459878818125813
Tax burden factor: 0.8511957169662469
ROE archetype: Standard Business
DuPont ROE decomposition for CVC.AX (annual period ending 2023-06-30)
ROE: 7.6510263217790255%
Net margin: 17.39431649481214%
Asset turnover: 0.27818078805697566
Equity multiplier (leverage): 1.5811941359406219
EBIT margin: 12.594586977070099%
Interest burden factor: 1.9195923597039142
Tax burden factor: 0.7194728752086564
ROE archetype: Standard Business
DuPont ROE decomposition for CVC.AX (annual period ending 2024-06-30)
ROE: -1.4028982134391779%
Net margin: -31.972813750173916%
Asset turnover: 0.025469014871696803
Equity multiplier (leverage): 1.7227932335241947
EBIT margin: -59.94866683057703%
ROE archetype: Low Return
DuPont ROE decomposition for CVC.AX (annual period ending 2025-06-30)
ROE: 0.6756159388856293%
Net margin: 5.800761545648589%
Asset turnover: 0.0611019002692438
Equity multiplier (leverage): 1.9061635323723387
EBIT margin: 12.069807991220438%
Interest burden factor: -1.3515109086065102
ROE archetype: Low Return
DuPont ROE decomposition for CVCB3.SA (annual period ending 2022-12-31)
ROE: -136.95683771486364%
Net margin: -35.48156303848657%
Asset turnover: 0.31182499541807335
Equity multiplier (leverage): 12.378557886754308
EBIT margin: -0.03020641047155563%
ROE archetype: Low Return
DuPont ROE decomposition for CVCB3.SA (annual period ending 2023-12-31)
ROE: -101.67970694039883%
Net margin: -31.889662104153725%
Asset turnover: 0.3755705326730063
Equity multiplier (leverage): 8.489710052928
EBIT margin: -9.826759452498449%
ROE archetype: Low Return
DuPont ROE decomposition for CVCB3.SA (annual period ending 2024-12-31)
ROE: -15.82182290616237%
Net margin: -7.27362691736764%
Asset turnover: 0.31653726000503973
Equity multiplier (leverage): 6.871960574062717
EBIT margin: 4.564800744388755%
Interest burden factor: -1.2854367435047414
ROE archetype: Low Return
DuPont ROE decomposition for CVCB3.SA (annual period ending 2025-12-31)
ROE: -8.616028385634626%
Net margin: -2.7500969100963184%
Asset turnover: 0.4166817280235665
Equity multiplier (leverage): 7.51890619080922
EBIT margin: 15.41807720963417%
Interest burden factor: -0.0031547253341002277
ROE archetype: Low Return
DuPont ROE decomposition for CVR (annual period ending 2022-12-31)
ROE: 9.25435729112766%
Net margin: 8.522933446567087%
Asset turnover: 1.0005919801587617
Equity multiplier (leverage): 1.085175919112391
EBIT margin: -3.4987720543459013%
Tax burden factor: 0.7850863035911941
ROE archetype: Standard Business
DuPont ROE decomposition for CVR (annual period ending 2023-12-31)
ROE: -15.456713100944633%
Net margin: -13.969857928795996%
Asset turnover: 1.025357749134387
Equity multiplier (leverage): 1.0790702979422562
EBIT margin: -18.526398068384633%
ROE archetype: Low Return
DuPont ROE decomposition for CVR (annual period ending 2024-12-31)
ROE: -24.416062830117504%
Net margin: -20.80887693004391%
Asset turnover: 1.0541429019493906
Equity multiplier (leverage): 1.1130828809047504
EBIT margin: -19.135603719575624%
ROE archetype: Low Return
DuPont ROE decomposition for CVR (annual period ending 2025-12-31)
ROE: -5.5741308916842325%
Net margin: -3.883843320212863%
Asset turnover: 1.1951701776409571
Equity multiplier (leverage): 1.2008415686467835
EBIT margin: -5.508148722887488%
ROE archetype: Low Return
DuPont ROE decomposition for CVS (quarterly period ending 2025-03-31)
ROE: 2.310984308131241%
Net margin: 1.8839599103480358%
Asset turnover: 0.3700843163722441
Equity multiplier (leverage): 3.3145506419400856
EBIT margin: 3.567048674250434%
Interest burden factor: 0.7756372258446947
Tax burden factor: 0.680932365303783
ROE archetype: Low Return
DuPont ROE decomposition for CVS (quarterly period ending 2025-06-30)
ROE: 1.320306994006246%
Net margin: 1.0321993630895212%
Asset turnover: 0.38493718964524215
Equity multiplier (leverage): 3.3229320901843384
EBIT margin: 2.40711722185715%
Interest burden factor: 0.6917261654766904
Tax burden factor: 0.6199149969641773
ROE archetype: Low Return
DuPont ROE decomposition for CVS (quarterly period ending 2025-09-30)
ROE: -5.276747134294874%
Net margin: -3.8640627582117406%
Asset turnover: 0.40053341639574047
Equity multiplier (leverage): 3.409442390532387
EBIT margin: 2.4477257924973994%
Interest burden factor: -1.3828435266084194
ROE archetype: Low Return
DuPont ROE decomposition for CVS (quarterly period ending 2025-12-31)
ROE: 3.963849904371953%
Net margin: 2.784479577644688%
Asset turnover: 0.41540683678382284
Equity multiplier (leverage): 3.426884950030978
EBIT margin: 1.9982401861996537%
Interest burden factor: 0.6410984848484849
Tax burden factor: 2.173559822747415
ROE archetype: Low Return
DuPont ROE decomposition for CVS (quarterly period ending 2026-03-31)
ROE: 3.8648795247648984%
Net margin: 2.9444566148208633%
Asset turnover: 0.3965394699434564
Equity multiplier (leverage): 3.310124886452009
EBIT margin: 4.66014777049768%
Interest burden factor: 0.8414529914529915
Tax burden factor: 0.7508887760284408
ROE archetype: Low Return
DuPont ROE decomposition for CVS.DE (annual period ending 2022-12-31)
ROE: 6.029065473951149%
Net margin: 1.3418427311941996%
Asset turnover: 1.4126251232066587
Equity multiplier (leverage): 3.1806908275160586
EBIT margin: 5.051679706760692%
Interest burden factor: 0.35825659914057706
Tax burden factor: 0.7414324880054832
ROE archetype: Standard Business
DuPont ROE decomposition for CVS.DE (annual period ending 2023-12-31)
ROE: 11.277248071156633%
Net margin: 2.338893609409239%
Asset turnover: 1.4969613161423674
Equity multiplier (leverage): 3.2209359522927126
EBIT margin: 4.080486114216717%
Interest burden factor: 0.7653263922186451
Tax burden factor: 0.7489483576479012
ROE archetype: Standard Business
DuPont ROE decomposition for CVS.DE (annual period ending 2024-12-31)
ROE: 6.056469291049185%
Net margin: 1.2376310657736267%
Asset turnover: 1.482509946455165
Equity multiplier (leverage): 3.30088733706995
EBIT margin: 2.600527347783986%
Interest burden factor: 0.6341413099535843
Tax burden factor: 0.7504879635653872
ROE archetype: Standard Business
DuPont ROE decomposition for CVS.DE (annual period ending 2025-12-31)
ROE: 2.3399862353750858%
Net margin: 0.4397277070736966%
Asset turnover: 1.5868361904122916
Equity multiplier (leverage): 3.35349277357192
EBIT margin: 2.5829028495250794%
Interest burden factor: 0.20568127106403467
Tax burden factor: 0.8277153558052435
ROE archetype: Low Return
DuPont ROE decomposition for CVV.V (annual period ending 2022-04-30)
ROE: -43.91421673057804%
Asset turnover: 0
Equity multiplier (leverage): 1.1496946456469253
ROE archetype: Low Return
DuPont ROE decomposition for CVV.V (annual period ending 2023-04-30)
ROE: -68.56730755895391%
Asset turnover: 0
Equity multiplier (leverage): 1.2052118920268313
ROE archetype: Low Return
DuPont ROE decomposition for CVV.V (annual period ending 2024-04-30)
ROE: -61.33756305083994%
Asset turnover: 0
Equity multiplier (leverage): 1.1981366945857577
ROE archetype: Low Return